@article{17921f7dade24eba83ef35415154f96b,
title = "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?",
keywords = "COVID-19, Parkinson's disease",
author = "Paulina Gonzalez-Latapi and Conor Fearon and Alfonso Fasano and Lang, {Anthony E.}",
note = "Funding Information: This study was supported in part by Parkinson's Canada through their support of the fellowship training of PGL. Funding agencies: Funding Information: P.G.L., C.L., and A.F. report no disclosures. A.E.L. has intellectual property rights with AbbVie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions; is a consultant for Jazz Pharma, PhotoPharmics, and Sunovion; is on the advisory boards of Sun Pharma, AbbVie, and Sunovion; is employed by Brain Canada, Canadian Institutes of Health Research, Corticobasal Degeneration Solutions, Edmond J Safra Philanthropic Foundation, Michael J. Fox Foundation, the Ontario Brain Institute, Parkinson Foundation, Parkinson Canada, and W. Garfield Weston Foundation; has received honoraria from the University Health Network and University of Toronto; and has received grants from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press.",
year = "2021",
month = feb,
doi = "10.1002/mds.28469",
language = "English (US)",
volume = "36",
pages = "277",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "2",
}